1-11 of 11
U Creutzig
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Addition of Liposomal Daunorubicin (DaunoXome®) to FLAG Significantly Improves Treatment Response in Pediatric Relapsed AML: Final Results From the International Randomised Phase III Study Relapsed AML 2001/01.

G.J.L. Kaspers, M. Zimmermann, D. Reinhardt, B. Gibson, R. Tamminga, O. Aleinikova, H. Armendariz, M. Dworzak, S. Ha, L. Hovi, A. Maschan, A. Baruchel, Y. Bertrand, B. Razzouk, C. Rizzari, P. Smisek, O. Smith, B. Stark, U. Creutzig
Journal: Blood
Blood (2009) 114 (22): 18.
https://doi.org/10.1182/blood.V114.22.18.18
Published: 2009
Journal Articles

Prognostic Significance of Time to Relapse in Pediatric AML: Results from the International Randomised Phase III Study Relapsed AML 2001/01

G.J.L. Kaspers, M. Zimmermann, D. Reinhardt, B. Gibson, R. Tamminga, H. Armendariz, M. Dworzak, S. Ha, L. Hovi, A. Maschan, A. Baruchel, Y. Bertrand, B. Razzouk, C. Rizzari, P. Smisek, O. Smith, B. Stark, U. Creutzig
Journal: Blood
Blood (2008) 112 (11): 2976.
https://doi.org/10.1182/blood.V112.11.2976.2976
Published: 2008
Journal Articles

Long-Term Continuing Second Complete Remission (CCR2) despite Allogeneic Stem Cell Transplantation in CR1: Results from the International Randomised Phase III Study Pediatric Relapsed AML 2001/01

G.J.L. Kaspers, M. Zimmermann, D. Reinhardt, B. Gibson, R. Tamminga, H. Armendariz, M. Dworzak, S. Ha, L. Hovi, A. Maschan, A. Baruchel, Y. Bertrand, B. Razzouk, C. Rizzari, P. Smisek, O. Smith, B. Stark, U. Creutzig
Journal: Blood
Blood (2008) 112 (11): 2977.
https://doi.org/10.1182/blood.V112.11.2977.2977
Published: 2008
Journal Articles

Distribution and Outcome According to Cytogenetics in 502 Paediatric AML Patients Treated in Study AML-BFM 98.

Christine von Neuhoff, MD, Jutta Bradtke, Martin Zimmermann, PhD, Jean-Pierre Bourquin, MD, PhD, David Betts, BSc, Jan Stary, MD, PhD, Zuzana Zemanova, MD, Michael N Dworzak, MD, PhD, Dirk Reinhardt, MD, PhD, U. Creutzig
Journal: Blood
Blood (2008) 112 (11): 1510.
https://doi.org/10.1182/blood.V112.11.1510.1510
Published: 2008
Journal Articles

Prognostic Significance of Early Treatment Response in Pediatric Relapsed Acute Myeloid Leukemia: Results from the International Study Relapsed AML 2001/01.

Gertjan J. Kaspers, M. Zimmermann, D. Reinhardt, R. Tamminga, B. Gibson, H. Armendariz, M. Dworzak, S. Ha, L. Hovi, A. Maschan, N. Philippe, B. Razzouk, C. Rizzari, P. Smisek, O. Smith, B. Stark, A. Will, U. Creutzig
Journal: Blood
Blood (2007) 110 (11): 1843.
https://doi.org/10.1182/blood.V110.11.1843.1843
Published: 2007
Journal Articles

Relapsed Acute Myeloid Leukemia in Children and Adolescents: Interim Results of the International Randomised Phase III Study “Relapsed AML 2001/01”.

Gertjan J. Kaspers, M. Zimmermann, G. Fleischhack, R. Tamminga, B. Gibson, H. Armendariz, M. Dworzak, S. Ha, L. Hovi, A. Maschan, N. Philippe, B. Razzouk, C. Rizzari, P. Smisek, O. Smith, B. Stark, U. Creutzig
Journal: Blood
Blood (2005) 106 (11): 897.
https://doi.org/10.1182/blood.V106.11.897.897
Published: 2005
Journal Articles

Relationship Between Major Vault Protein/Lung Resistance Protein, Multidrug Resistance-Associated Protein, P-Glycoprotein Expression, and Drug Resistance in Childhood Leukemia

M.L. den Boer, R. Pieters, K.M. Kazemier, M.M.A. Rottier, C.M. Zwaan, G.J.L. Kaspers, G. Janka-Schaub, G. Henze, U. Creutzig, R.J. Scheper, A.J.P. Veerman
Journal: Blood
Blood (1998) 91 (6): 2092–2098.
https://doi.org/10.1182/blood.V91.6.2092
Published: 1998
Journal Articles

Chronic Myelomonocytic Leukemia in Childhood: A Retrospective Analysis of 110 Cases

C.M. Niemeyer, M. Aricó, G. Basso, A. Biondi, A. Cantú Rajnoldi, U. Creutzig, O. Haas, J. Harbott, H. Hasle, G. Kerndrup, F. Locatelli, G. Mann, B. Stollmann-Gibbels, E.Th. van‘t Veer-Korthof, E. van Wering, M. Zimmermann, Members of the European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS)
Journal: Blood
Blood (1997) 89 (10): 3534–3543.
https://doi.org/10.1182/blood.V89.10.3534
Published: 1997
Journal Articles

Clinical significance of surface antigen expression in children with acute myeloid leukemia: results of study AML-BFM-87

U Creutzig, J Harbott, C Sperling, J Ritter, M Zimmermann, H Loffler, H Riehm, G Schellong, WD Ludwig
Journal: Blood
Blood (1995) 86 (8): 3097–3108.
https://doi.org/10.1182/blood.V86.8.3097.3097
Published: 1995
Journal Articles

Identification of two risk groups in childhood acute myelogenous leukemia after therapy intensification in study AML-BFM-83 as compared with study AML-BFM-78. AML-BFM Study Group

U Creutzig, J Ritter, G Schellong
Journal: Blood
Blood (1990) 75 (10): 1932–1940.
https://doi.org/10.1182/blood.V75.10.1932.1932
Published: 1990
Journal Articles

Improved treatment results in childhood acute myelogenous leukemia: a report of the German cooperative study AML-BFM-78

U Creutzig, J Ritter, H Riehm, HJ Langermann, G Henze, H Kabisch, D Niethammer, H Jurgens, B Stollmann, U Lasson
Journal: Blood
Blood (1985) 65 (2): 298–304.
https://doi.org/10.1182/blood.V65.2.298.298
Published: 1985